The most recent MoneyTree report from PwC and CB Insights highlights the biggest biotech-related and medical devices VC deals in Q2, which include investments in companies like Grail, Allogene Therapeutics, RefleXion Medical and Mevion Medical Systems.
Startups in life sciences raked in $2.49 billion through 156 deals from venture capitalists in the third quarter. Here are the 10 companies that garnered the most.
Help shape the future of healthcare benefits by sharing your insights.
Several biotechnology companies secured impressive venture funding this quarter, despite the fact that biotech investment is flat, a new PwC report shows.